Zusammenfassung
Bei unbehandelten oder mit Induktoren bzw. Inhibitoren der mikrosomalen Monooxygenase vorbehandelten männlichen NMRI Mäusen wurden fünf Stunden nach i.p.-Injektion von 14C-Dimethylnitrosamin (10 mg/kg) in den einzelnen Zellkompartimenten der Leber die gesamte und spezifische Radioaktivität von Proteinen, DNA und RNA bestimmt. Zur Differenzierung von Alkylierung und 14C1-Inkorporation wurden DNA und funktionsspezifische RNA-Formen durch Chromatographie über MAK, Oligo-(dt)-Zellulose und 3-ABBS isoliert und ihre Basen nach Hydrolyse durch Ionenaustausch-Chromatographie getrennt. Vorbehandlung mit den Induktoren Phenobarbital und 3-Methylcholanthren führte zur Erniedrigung der Alkylierungsraten, Vorbehandlung mit den Inhibitoren SKF 525 A und CFT 1201 zu ihrer Steigerung. Unspezifische Faktoren wie Unterschiede in Resorption und Bioverfügbarkeit von DMN, Veränderungen von Alkylierungskinetik oder Alkylierungsprofil konnten als Ursachen dieser Effekte ausgeschlossen werden. Unter der Voraussetzung, daß die oxidative Desalkylierung von DMN durch Induktoren und Inhibitoren der Monooxygenase in gleicher Weise beeinflußt wird wie andere cyt. P 450 abhängige N-Dimethylierungen, widersprechen die Ergebnisse dem allgemein angenommenen Aktivierungsmechanismus der Nitrosamine. Die Problematik der darüber mitgeteilten kontroversen Daten wird diskutiert.
Summary
Male mice were pretreated with various drugs, which are known either to induce or to inhibit cytochrome P 450 function. Five hours after the administration of 14C-dimethylnitrosamine (10 mg/kg) in pretreated and control mice, total and specific radioactivities of cellular macromolecules of the liver were determined. Various types of nucleic acids were extracted and hydrolyzed, and the bases and nucleotides separated by ion-exchange-chromatography. Radioactivity · resulting from incorporation and alkylation was measured. Pretreatment of mice with the inducers phenobarbital and 3-Methylcholanthrene decreased the alkylation rates, while administration of the inhibitors SKF 525 A and CFT 1201 caused an increase. These results appear to contradict the accepted activation mechanism of nitrosamines if DMN demethylation as catalyzed by cyt. P 450 is influenced in the same way as other cyt. P 450 dependent reactions.
Abbreviations
- DMN:
-
dimethylnitrosamine
- PB:
-
phenobarbital
- 3-MC:
-
3-Methylcholanthrene
- SKF 525 A:
-
2-diethylaminoethyl-2,2-diphenylvalerate HCl
- CFT:
-
1201 2-diethylaminoethyl-2-phenyl-2-(2-propene)-4-penten-1-oate HCl
- cyt. P 450:
-
cytchrome P 450
- MAK:
-
Methylalbumin-Kieselguhr
- 3 ABBS:
-
3-aminobenzeneboronic acid
References
Appel, K.E.: Bedeutung der Cytochrom P 450-Funktion für Metabolismus, Alkylierungsintensität und carcinogene Wirksamkeit von Dimethylnitrosamin. Tübingen: Thesis 1976
Arcos, J.C., Bryant, G.M., Venkatesan, N., Argus, M.F.: Repression of dimethylnitrosamine-demethylase by typical inducers of microsomal mixed-functions oxidases. Biochem. Pharm. 24, 1544–1547 (1975)
Bartsch, H., Malaveille, C., Montesano, R.: In vitro metabolism and microsome-mediated mutagenicity of dialkylnitrosamines in rat, hamster, and mouse tissues. Cancer Res. 35, 644–651 (1975)
Bickel, M.H.: The pharmacology and biochemistry of N-oxides. Pharmacol. Rev. 21, 325–355 (1969)
Bochert, G.: Comparative studies on the formation of methylated bases in DNA of adult and fetal mouse tissues by dimethylnitrosamine in vivo. New approaches to the evaluation of abnormal embryonic development, pp. 554–572. Stuttgart: Thieme 1975
Burton, K.: A study of conditions and mechanisms of diphenylamine reaction for the colorimetric estimation of DNA. Biochem. J. 62, 315–323 (1956)
Czygan, P., Greim, H., Garro, J.A., Hutterer, F., Schaffner, P., Popper, H., Rosenthal, O., Cooper, Y.D.: Microsomal metabolism of dimethylnitrosamine and the cytochrome P 450 dependency of its activation to a mutagen. Cancer Res. 33, 2983–2986 (1973)
D'Acosta, N., Castro, J.A., de Castro, C.R., Diaz Gomez, M.I., de Ferregra, E.C., de Fenos, O.M.: Mechanism of dimethylnitrosamine and carbon tetrachloride-induced liver necrosis: Similarities and differences. Toxicol. Appl. Pharmacol. 32, 474–481 (1975)
Dutton, A.H., Heath, D.F.: The preparation of 14C-dimethylamine and 14C-dimethylnitrosamine. J. Chem. Soc. 2, 1892–1894 (1956)
Franklin, M.R.: Inhibition of mixed-function oxidations by substrates forming reduced cytochrome P 450 metabolic-intermediate complexes. Pharmacol. Ther. Arch. 2, 227–245 (1977)
Frantz, C.N., Malling, H.V.: Factors affecting metabolism and mutagenicity of dimethylnitrosamine and diethylnitrosamine. Cancer Res. 35, 2307–2314 (1975)
Georgiev, G.P., Mantieva, V.L.: The isolation of DNA-like RNA and ribosomal RNA from the nucleolo-chromosomal apparatus of mammalian cells. Biochim. Biophys. Acta 61, 153–154 (1962)
Gräser, H.: Biochemisches Praktikum. Basel: Winter 1971
Hoch-Ligeti, C., Argus, M.F., Arcos, J.C.: Combined carcinogenic effects of Dimethylnitrosamine and 3-Methylcholanthrene in the rat. J. Natl. Canc. Inst. 40, 535–540 (1968)
Holtzman, J.L., Rumack, H.B., Erickson, R.R.: Spectrophotometric and radiometric studies on the in vivo binding of phenobarbital to hepatic microsomes. Arch. Biochem. Biophys. 173, 710–719 (1976)
Ishida, T., Kan, J., Kano-Sueoka, T.: Procedures in nucleic acid research, Vol. 2, Cantini, G.L., Davis, D.R. (eds.). New York: Harper and Row 1971
Kato, R., Shoji, H., Takanaka, A.: Metabolism of carcinogenic compounds. I. Effect of Phenobarbital and Methylcholanthrene on the activities of N-demethylation of carcinogenic compounds by liver microsomes of male and female rats. Gann 58, 467–469 (1967)
Krüger, F.W.: Untersuchungen über den Zusammenhang zwischen alkylierender und carcinogener Wirkung. Habil.-Schrift, heidelberg 1971
Kunz, W., Schaude, G., Siess, M.: Die Beeinflussung der Nitrosamincarcinogenese durch lebervergrößernde Pharmaka. Berichte des Eur Cancer Meeting. Wien: Verlag der Wien. Akad. 1967
Kunz, W., Schaude, G., Thomas, C.: Die Beeinflussung der Nitrosamincarcinogenese durch Phenobarbital und Halogenkohlenwasserstoffe. Z. Krebsforsch. 72, 291–304 (1969)
Kunz, W., Stöckle, G., Appel, K.E.: Quantitative Analyses of enzyme-deficient cell areas to assess early precancerous alterations of hepatocarcinogenic substances. Naunyn-Schmiedebergs Arch. Pharmacol. (Suppl.) 293, R 65 (1976)
Kunz, W., Appel, K.E., Rickart, R., Schwarz, M., Stöckle, G.: Enhancement and inhibition of carcinogenic effectiveness of nitrosamines. In: Primary liver tumors. Remmer, H., Bolt, H.M., Bannasch, P., Popper, H. (eds.) Lancaster: MTP Press 1978
Lake, B.G., Phillips, J.C., Heading, C.E., Gangolli, S.D.: Studies on the in vitro metabolism of Dimethylnitrosamine by rat liver. Toxicology 5, 297–309 (1976)
Lerman, M.I., Abakumora, O.Yu., Kucenco, N.G., Gorbachera, L.B., Kukushkina, G.V., Serehryangi, A.M.: Different degradation rates of alkylated RNA protein and lipids in normal and tumor cells. Cancer Res. 34, 1536–1541 (1974)
Lowry, O.H., Brough, N.J.R., Farr, A.L., Rondall, R.J.: Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265–275 (1951)
Makiura, S., Aoe, H., Sugihara, S., Hirao, K., Arai M., Ito, N.: Inhibitory effect of polychlorinated Biphyenyls on liver tumorigenesis in rats treated with 3′-methyl-4-dimethylaminoazobenzene, N-2-fluorenylacetamide, and diethylnitrosamine. J. Natl. Cancer Inst. 53, 1253–1256 (1974)
Mandell, J.D., Hershey, A.D.: A fractionating column for analysis of nucleic acids. Anal. Biochem. 1, 66–77 (1960)
Mc Lean, A.E.M., Day, P.A.: The use of new methods to measure: The effect of diet and inducers of microsomal enzyme synthesis on cytochrome P 450 in liver homogenates, and on metabolism of dimethylnitrosamine. Biochem. Pharmacol. 23, 1173–1180 (1974)
Montesano, R., Bartsch H.: Mutagenic and carcinogenic N-nitroso compounds: possible environmental hazards. Mutat. Res. 32, 179–228 (1976)
Meybaum, W.: Über die Bestimmung kleiner Pentosemengen in Derivaten der Adenylsäure. Hoppe-Seylers' Z. Physiol. Chem. 238, 117–121 (1939)
Preussmann, R.: Zum oxidativen Abbau von Nitrosaminen mit Enzym-freien Modell-Systemen. Arzneimittelforsch. 7, 769–774 (1964)
Rogan, E., Cavalieri, E.: 3-Methylcholanthrene-inducible binding of aromatic Hydrocarbons to DNA in purified rat liver nuclei. Biochem. Biophys. Res. Commun. 58, 1119–1126 (1974)
Sherrer, K., Darnell, J.E.: Sedimentation characteristics of rapidly labeled RNA from hela cells. Biochem. Biophys. Res. Commun. 7, 486–490 (1962)
Somogyi, M.: Notes on sugar determination. J. Biol. Chem. 195, 19–23 (1952)
Stier, A.: Was geschieht mit Arzneistoffen im Körper? Umschau 75, 429–434 (1975)
Uehleke, H.: The role of cytochrome P 450 in the N-oxidation of individual amines. Drug Metab. Dispos. 1, 299–313 (1973)
Venkatesan, N., Arcos, J.C., Argus, M.F.: Differential effect of polycyclic hydrocarbons on the demethylation of the carcinogen dimethylnitrosamine by rat tissues. Life Sci. 7, 1111–1119 (1968)
Wallaas, O., Wallaas, E.: Effect of epinephrine on rat diaphragm. J. Biol. Chem. 187, 769–776 (1950)
Watanabe, M., Ariji, F., Takusagawa, K., Konno, K.: Aryl Hydrocarbon hydroxylase in liver nuclei of C3H/He and DBA/2 mice. Gann 66, 399–409 (1975)
Weisburger, I.H., Madison, R.M., Ward, I.M., Viguera, C., Weisburger, E.K.: Modification of diethylnitrosamine liver carcinogenesis with phenobarbital but not with immunosuppression. J. Natl. Cancer Inst. 54, 1185–1188 (1975)
Ziegler, D.M., McKee, E.M., Poulsen, L.L.: Microsomal flavoprotein-catalyzed N-oxidation of Arylamines. Drug Metab. Dispos. 1, 314–321 (1973)
Author information
Authors and Affiliations
Additional information
This work was supported by the Deutsche Forschungsgemeinschaft
Rights and permissions
About this article
Cite this article
Appel, K.E., Schwarz, M., Rickart, R. et al. Influences of inducers and inhibitors of the microsomal monooxygenase system on the alkylating intensity of dimethylnitrosamine in mice. J Cancer Res Clin Oncol 94, 47–61 (1979). https://doi.org/10.1007/BF00405349
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00405349